ArticleEuropean journal of medical research2025
Clinical application of laparoscopic pectopexy in the treatment of pelvic organ prolapse: efficacy and safety.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Post-Hysterectomy Vaginal Vault Prolapse: Current Perspectives and Decision-Making Considerations for Surgical Treatment.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo evaluate the efficacy and safety of laparoscopic pectopexy in the treatment of female pelvic organ prolapse (POP).
methodsA total of 40 patients with anterior and/or apical compartment prolapse who underwent laparoscopic pectopexy at the First Affiliated Hospital of Zhengzhou University from January 2022 to June 2023 were included in this retrospective study. Clinical data and outcomes were collected and analyzed. Pelvic Organ Prolapse Quantification (POP-Q), patients global impression of improvement (PGI-I), pelvic floor distress inventory-20 (PFDI-20), pelvic organ prolapse/urinary incontinence sexual questionnaire-12 (PISQ-12), and generalized anxiety disorder 7-item (GAD-7) scale were applied to evaluate the subjective and objective response by postoperative quality of life and sexual function. Intraoperative and postoperative complications were also analyzed to evaluate surgical safety.
resultsAll the 40 patients successfully completed the operation without intraoperative complications. During regular follow-up, one case had urinary retention after the operation, one case (2.5%) had mesh exposure and two cases (5.0%) had chronic pelvic pain. The objective and subjective response rates were 97.5% and 90% at 3 months after operation, 87.5% and 87.5% at 12 months after operation, respectively. The scores of PISQ-12, PFDI-20, and GAD-7 at 12 months after operation were significantly improved when compared with those before operation (P < 0.05).
conclusionLaparoscopic pectopexy is an alternative safe and effective surgical approach for the treatment of POP with anterior and apical pelvic defects. This surgical approach effectively restore the pelvic anatomy, and significantly improved quality of life and sexual function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.